Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Association of Plasma Ghrelin Levels with Insulin Resistance in Type 2 Diabetes Mellitus among Saudi Subjects.

Al Qarni AA, Joatar FE, Das N, Awad M, Eltayeb M, Al-Zubair AG, Ali ME, Al Masaud A, Shire AM, Gumaa K, Giha HA.

Endocrinol Metab (Seoul). 2017 Jun;32(2):230-240. doi: 10.3803/EnM.2017.32.2.230. Epub 2017 May 29.

2.

Treating Diabetes Mellitus: Pharmacophore Based Designing of Potential Drugs from Gymnema sylvestre against Insulin Receptor Protein.

Hossain MU, Khan MA, Rakib-Uz-Zaman SM, Ali MT, Islam MS, Keya CA, Salimullah M.

Biomed Res Int. 2016;2016:3187647. doi: 10.1155/2016/3187647. Epub 2016 Feb 28.

3.

The glycaemic outcomes of Cinnamon, a review of the experimental evidence and clinical trials.

Medagama AB.

Nutr J. 2015 Oct 16;14:108. doi: 10.1186/s12937-015-0098-9. Review.

4.

Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms.

Arcidiacono B, Iiritano S, Nocera A, Possidente K, Nevolo MT, Ventura V, Foti D, Chiefari E, Brunetti A.

Exp Diabetes Res. 2012;2012:789174. doi: 10.1155/2012/789174. Epub 2012 Jun 4. Review.

5.

Molecular docking studies of banana flower flavonoids as insulin receptor tyrosine kinase activators as a cure for diabetes mellitus.

Ganugapati J, Baldwa A, Lalani S.

Bioinformation. 2012;8(5):216-20. doi: 10.6026/97320630008216. Epub 2012 Mar 17.

6.

HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway.

Chiefari E, Nevolo MT, Arcidiacono B, Maurizio E, Nocera A, Iiritano S, Sgarra R, Possidente K, Palmieri C, Paonessa F, Brunetti G, Manfioletti G, Foti D, Brunetti A.

Sci Rep. 2012;2:251. doi: 10.1038/srep00251. Epub 2012 Feb 7.

7.

Low-frequency variants in HMGA1 are not associated with type 2 diabetes risk.

Marquez M, Huyvaert M, Perry JR, Pearson RD, Falchi M, Morris AP, Vivequin S, Lobbens S, Yengo L, Gaget S, Pattou F, Poulain-Godefroy O, Charpentier G, Carlsson LM, Jacobson P, Sjöström L, Lantieri O, Heude B, Walley A, Balkau B, Marre M, Froguel P, Cauchi S; DIAGRAM Consortium.

Diabetes. 2012 Feb;61(2):524-30. doi: 10.2337/db11-0728. Epub 2011 Dec 30.

8.

Proprotein convertases process Pmel17 during secretion.

Leonhardt RM, Vigneron N, Rahner C, Cresswell P.

J Biol Chem. 2011 Mar 18;286(11):9321-37. doi: 10.1074/jbc.M110.168088. Epub 2011 Jan 19.

9.

Genetics of polycystic ovary syndrome.

Prapas N, Karkanaki A, Prapas I, Kalogiannidis I, Katsikis I, Panidis D.

Hippokratia. 2009 Oct;13(4):216-23.

10.

New target genes for the peroxisome proliferator-activated receptor-γ (PPARγ) antitumour activity: Perspectives from the insulin receptor.

Foti DP, Paonessa F, Chiefari E, Brunetti A.

PPAR Res. 2009;2009:571365. doi: 10.1155/2009/571365. Epub 2009 Jun 29.

11.
12.

Insulin-mimetic and insulin-sensitizing activities of a pentacyclic triterpenoid insulin receptor activator.

Jung SH, Ha YJ, Shim EK, Choi SY, Jin JL, Yun-Choi HS, Lee JR.

Biochem J. 2007 Apr 15;403(2):243-50.

13.
14.

Human diabetes associated with defects in nuclear regulatory proteins for the insulin receptor gene.

Brunetti A, Brunetti L, Foti D, Accili D, Goldfine ID.

J Clin Invest. 1996 Jan 1;97(1):258-62.

15.
17.
18.
19.
20.

Legionella micdadei protein kinase catalyzes phosphorylation of tubulin and phosphatidylinositol.

Saha AK, Dowling JN, Mukhopadhyay NK, Glew RH.

J Bacteriol. 1989 Sep;171(9):5103-10.

Supplemental Content

Support Center